Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Thymopentin (TP-5) vs Thymalin — Peptide Comparison

Thymopentin (TP-5) vs Thymalin — Peptide Comparison Thymopentin (TP-5) vs Thymalin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymopentin (TP-5) 1–2 mg Thymalin 5–10

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

Thymopentin (TP-5) vs Thymalin — Peptide Comparison Thymopentin (TP-5) vs Thymalin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymopentin (TP-5) 1–2 mg Thymalin 5–10 mg Frequency Once daily Administration Subcutaneous injection Intramuscular injection Cycle Length 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Limited human trials Efficacy Immune Enhancement Cardiovascular Support Post-Recovery Support Immune Restoration Longevity Support Disease Prevention Technical Data Molecular Formula C30H49N9O9 Molecular Weight 679.8 Half-Life 30 seconds to few minutes in plasma Bioavailability Sustained release via subcutaneous route CAS Number 69558-55-0 Complex mixture; active dipeptide EW: C16H19N3O5 Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da Not precisely characterized for complex; immune effects persist weeks post-administration High via intramuscular or subcutaneous injection 63958-90-7 Protocols standard 50 mg Three times weekly 6 weeks to 48 weeks depending on indication Dose used in controlled clinical trials, e.g. 50 mg SC three times weekly in HIV and atopic dermatitis studies [5]. advanced 50 mg by slow IV Repeated injections (e.g. three times weekly) Several weeks Slow intravenous infusion was used in rheumatoid arthritis trials and may enhance in-vivo potency versus bolus dosing [5]. 5-10 mg reconstituted in saline 5-10 day course, often repeated every 6 months Reflects the Russian clinical course used in immune-restoration and gerontology protocols, typically 10 mg IM daily for 5-10 days [1]. 10 mg Up to 20 day course, repeated every 6 months Subcutaneous administration is used in community practice at the same 10 mg daily dosing; longer 20-day courses are described for cyclical immune support [1]. Applications Immune System Enhancement Thymopentin directly increases T-cell function and promotes dendritic cell maturation, making it ideal for people seeking to boost immune response naturally Cardiac Health Support Clinical trials show thymopentin improves ejection fraction and exercise capacity in elderly heart failure patients while enhancing immune markers Post-Surgery Recovery Helps restore immune function after major surgery and protects important immune responses during recovery period Aging Adults Seeking Immune Support Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy. Longevity and Anti-Aging Protocols Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols. Seasonal Illness Prevention Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward. Safety Profile Common Local injection site reaction Mild fatigue Transient fever Uncommon Muscle aches Mild headache Serious Allergic reaction No side effects in most patients Mild injection site reaction Transient low-grade fever Mild flu-like symptoms Temporary headache Severe allergic reaction Research Status FDA Status Research compound Safety Overview Thymopentin is well-tolerated with minimal side effects reported in clinical trials. Most adverse events are mild and local. No serious safety concerns have emerged from decades of clinical use in China and Europe. Contraindications xPregnancy and breastfeeding xActive malignancy (without medical supervision) xSevere immunosuppression xHypersensitivity to peptide medications Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods. xActive thymic tumors or malignancies xKnown hypersensitivity to animal-derived peptide products xPregnancy and breastfeeding (insufficient safety data) xSevere uncontrolled autoimmune disease without medical supervision Decision Guide Choose Thymopentin (TP-5) if... Immune system strengthening Recovering from illness or surgery Managing autoimmune conditions Supporting cardiac health in elderly patients Choose Thymalin if... Immune system restoration in aging adults Longevity and healthy aging support Reducing infection frequency and severity Multi-system health optimization